Milestone Pharmaceuticals Inc. (MIST) › Operating Cash FlowMilestone Pharmaceuticals Inc. (MIST) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$21.05M2019: -$51.15M2020: -$50.73M2021: -$33.22M2022: -$52.47M2023: -$46.42M2024: -$28.85M2025: -$49.04M-$49.04M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$49.04M-70.0%2024-$28.85M+37.9%2023-$46.42M+11.5%2022-$52.47M-57.9%2021-$33.22M+34.5%2020-$50.73M+0.8%2019-$51.15M-143.0%2018-$21.05M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share